共 32 条
- [1] Simone J, Aur RJA, Hustu HD, Pinkel D, “Total therapy” studies of acute lymphocytic leukemia in childhood. Current results and prospects for cure, Cancer, 30, (1972)
- [2] Sather H, Coccia P, Nesbit M, Level C, Hammond D, (1978)
- [3] Chard RL, Finkelstein JZ, Sonley MJ, McCreadie S, Weiner J, Sather H, Hammond D, Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6‐thioguanine, cyclophosphamide and oncovin (PATCO) combination chemotherapy – 163 patients, Med Pediatr Oncol, 3, (1978)
- [4] Sonley MJ, Nesbit M, Thatcher LG, Cytosine arabinoside, cyclophosphamide and vincristine in children with acute myelogenous leukemia, Proc Am Assoc Cancer Res, 12, (1977)
- [5] Evans DIK, Morris Jones PH, Morley CJ, Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunomycin, prednisone and mercaptopurine or thioguanine, Cancer, 36, (1975)
- [6] Pizzo PA, Henderson ES, Leventhal BG, Acute myelogenous leukemia in children: A preliminary report of combination chemotherapy, J Pediatr, 88, (1976)
- [7] Karon M, Sieger L, Leimbrock S, Finkelstein JZ, Nesbit ME, Swaney JJ, 5‐Azacytidine: A new active agent for the treatment of acute leukemia, Blood, 42, (1973)
- [8] VanHoff DD, Slavik M, Muggia FM, 5‐Azacytidine: A new anticancer drug with effectiveness in acute myelogenous leukemia, Ann Int Med, 85, (1976)
- [9] Mathe G, Amiel SL, Schwarzenberg L, Schneider M, Calton A, Schlumberger JR, Hayath M, DeVassal F, Active immunotherapy for acute lymphoblastic leukemia, Lancet, 1, (1969)
- [10] Treatment of acute lymphoblastic leukemia. Comparison of immunotherapy (BCG), intermittent methotrexate, and no therapy, after a five‐month intensive cytotoxic regimen (Concord Trial), Br Med J, 4, (1971)